bemfola
gedeon richter plc. - follitropin alfa - anovulation - køn hormoner og modulatorer af den genitale system, - in adult women:anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomiphene citrate;stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertilisation (ivf), gamete intra-fallopian transfer (gift) and zygote intra-fallopian transfer (zift);follitropin alfa in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. i kliniske forsøg skal disse patienter blev defineret ved en endogen serum lh niveau < 1. 2 ie / l. in adult men:follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human chorionic gonadotrophin (hcg) therapy.
clozapine "actavis" 100 mg tabletter
actavis group ptc ehf. - clozapin - tabletter - 100 mg
clozapine "actavis" 25 mg tabletter
actavis group ptc ehf. - clozapin - tabletter - 25 mg
clozapine "teva" 100 mg tabletter
teva b.v. - clozapin - tabletter - 100 mg
clozapine "teva" 25 mg tabletter
teva b.v. - clozapin - tabletter - 25 mg
clozapine "aristo" 25 mg tabletter
aristo pharma gmbh - clozapin - tabletter - 25 mg
clozapine "aristo" 100 mg tabletter
aristo pharma gmbh - clozapin - tabletter - 100 mg
encyzix
renable pharma limited - enclomifene citrate - hypogonadisme - køn hormoner og modulatorer af den genitale system, - behandling af hypogonadotrop hypogonadisme hos mænd.
clomicalm
virbac s.a. - clomipramine hydrochloride - psychoanaleptics - hunde - as an aid in the treatment of separation related disorders in dogs manifested by destruction and inappropriate elimination (defecation and urination) and only in combination with behavioural modification techniques.
puregon
n.v. organon - follitropin beta - infertility; hypogonadism - køn hormoner og modulatorer af den genitale system, - i den kvindelige:puregon er indiceret til behandling af kvindelig infertilitet i følgende kliniske situationer:anovulation (herunder polycystisk ovarie syndrom, pcos) hos kvinder, der ikke har responderet på behandling med clomifene citrate;kontrollerede æggestokkene hyperstimulation til at fremkalde udvikling af flere follikler i medicinsk assisteret reproduktion programmer (e. in-vitro-fertilisering / ægoplægning (ivf/et), gamete intrafallopian overførsel (gave) og icsi (intracytoplasmic sperm injection)). i den mandlige:mangelfuld spermatogenese på grund af hypogona.